Skip to main content

Table 2 Adverse Events

From: Long term follow-up of neoadjuvant chemotherapy for non-small cell lung cancer (NSCLC) investigating early positron emission tomography (PET) scan as a predictor of outcome

Toxicity Category

Grade

Number (%)

Fatigue

3

7 (28)

Pain

3

2 (8)

Metabolic/Laboratory

3

1 (4)

Pulmonary

3

3 (12)

Gastrointestinal

3

4 (16)

Dermatologic/skin

3

2 (8)

Neurologic

4

1 (4)

Allergy/Immunologic

3

1 (4)

  1. Note: Maximum grade per patient per body system presented. Number of evaluable patients: 25. Total number of patients with grade 3/4 toxicities: 10 (patients with multiple toxicities and are listed separately above)